Skip to main content
logo
vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
30.46
0.00 (0.00%)
At close: Sep 16, 2026, 4:00 PM EDT
30.28
-0.18 (-0.59%)
After-hours: Sep 16, 2026, 6:13 PM EDT

vTv Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
37849691235467
Market Cap Growth
163.46%445.89%288.02%-56.62%-18.92%-32.00%
Enterprise Value
29239852276493
Last Close Price
30.4639.9913.8111.5026.5139.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.27-89.38-26.7616.63
PB Ratio
4.817.706.36-1.269.254.38
P/TBV Ratio
4.817.707.45---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
7.92-51.49-31.6923.20

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.01-0.030.120.06
Net Debt / Equity Ratio
-1.10-1.38-2.560.48-1.96-0.83
Net Debt / EBITDA Ratio
9.372.711.520.350.510.63
Net Debt / FCF Ratio
5.173.521.450.470.710.65
Asset Turnover
0.65-0.04-0.070.20
Quick Ratio
12.3513.397.070.911.601.61
Current Ratio
12.4813.547.341.003.521.84
Return on Equity (ROE)
-15.80%-78.94%---238.10%-186.50%
Return on Assets (ROA)
-10.14%-32.00%-61.33%-72.03%-47.99%-62.28%
Return on Capital Employed (ROCE)
-11.50%-39.40%-73.10%-6391.50%-88.30%-118.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.26%-5.44%-20.31%-86.44%-35.48%-19.50%
FCF Yield
-4.43%-5.09%-27.84%-81.45%-29.70%-28.99%
Buyback Yield / Dilution
-74.02%-45.96%-176.79%-8.60%-22.58%-32.90%
SEC Filings: 10-K · 10-Q